{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:29:22Z","timestamp":1790922562686,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Women with polycystic ovary syndrome (PCOS) have an increased risk of pregnancy complications and fetal growth restriction is reported. Increased head size has been reported in PCOS-offspring exposed to intrauterine metformin. We aimed to explore whether maternal PCOS-status, and the use of metformin, during pregnancy affect fetal cerebral and placental circulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The Pilot (2000-2003) and the PregMet2 (2012-2017) studies are randomized controlled trials where women with PCOS were randomized to metformin or placebo in pregnancy. Individually pooled data from Doppler examinations at gestational week 32 from these RCT\u2019s were included in a post-hoc analysis of totally 64 participants. The pulsatility index (PI) z-scores of the fetal middle cerebral artery (MCA), umbilical artery (UmbA), and the cerebroplacental ratio (CPR) were compared between the metformin and placebo treated groups with a two-sample t-test. The PI z-scores of the women with PCOS were compared to low-risk reference populations of pregnant women. The PI z-scores were correlated with maternal BMI at inclusion, androgen levels measured at gestational week 32, percentage gestational weight gain from first trimester to gestational week 32 and offspring head circumference.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There was no significant difference in PI z-scores of fetal MCA, UmbA, and CPR between metformin and placebo treated women with PCOS, or between women with PCOS compared to low-risk reference populations. Maternal BMI, androgen levels, percentage gestational weight gain, and offspring head circumference did not correlate significantly with PI z-scores of fetal MCA, UmbA or CPR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Maternal PCOS and metformin exposure during pregnancy had no significant impact on placental and fetal cerebral pulsatility indices. The reported fetal growth restriction in PCOS-offspring and the larger head size in metformin exposed fetuses may not be explained by altered umbilical and cerebral pulsatility indices, or their relationship. These findings support the current clinical practice that fetoplacental Doppler assessment in PCOS pregnancies should follow standard obstetric indications. <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>The Pilot study was performed before trial registrations became mandatory and the trial was retrogradely registered on the 17th of August 2017. ClinicalTrials.gov Identifier: NCT03259919.\u00a0The PregMet 2 study was registered on the 26<jats:sup>th<\/jats:sup> of April 2012 at ClinicalTrials.gov Identifier: NCT01587378. The CircMet study was a sub-study of the PregMet 2 study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12884-025-07866-9","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:51:00Z","timestamp":1752137460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Placental and cerebral circulation in fetuses of mothers with polycystic ovary syndrome and the effect of Metformin exposure"],"prefix":"10.1186","volume":"25","author":[{"given":"Emma","family":"Nordtvedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrine","family":"Ebbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone S.","family":"L\u00f8vvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell \u00c5.","family":"Salvesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Salvesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Vanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte H.","family":"Kahrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"12","key":"7866_CR1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841\u201355.","journal-title":"Hum Reprod"},{"issue":"2","key":"7866_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544\u201351.","journal-title":"Hum Reprod"},{"key":"7866_CR3","unstructured":"International evidence based guideline for the assessment and management of polycystic ovary syndrome. https:\/\/www.monash.edu\/medicine\/sphpm\/mchri\/pcos\/guideline2018."},{"issue":"51","key":"7866_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004863","volume":"95","author":"HF Yu","year":"2016","unstructured":"Yu HF, Chen HS, Rao DP, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2016;95(51): e4863.","journal-title":"Medicine"},{"issue":"2","key":"7866_CR5","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43\u201364.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"7866_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/uog.23698","volume":"58","author":"A Bhide","year":"2021","unstructured":"Bhide A, Acharya G, Baschat A, Bilardo CM, Brezinka C, Cafici D, et al. ISUOG practice guidelines (updated): use of doppler velocimetry in obstetrics. Ultrasound Obstet Gynecol. 2021;58(2):331\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"7866_CR7","doi-asserted-by":"crossref","unstructured":"L\u00f8vvik TS, Carlsen SM, Salvesen \u00d8, Steffensen B, Bixo M, G\u00f3mez-Real F, et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(4):256\u201366.","DOI":"10.1016\/S2213-8587(19)30002-6"},{"issue":"2","key":"7866_CR8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1210\/jc.2017-01191","volume":"103","author":"A Hjorth-Hansen","year":"2018","unstructured":"Hjorth-Hansen A, Salvesen O, Engen Hanem LG, Eggebo T, Salvesen KA, Vanky E, et al. Fetal growth and birth anthropometrics in Metformin-Exposed offspring born to mothers with PCOS. J Clin Endocrinol Metab. 2018;103(2):740\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7866_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","volume":"3","author":"LGE Hanem","year":"2019","unstructured":"Hanem LGE, Salvesen \u00d8, Juliusson PB, Carlsen SM, Nossum MCF, Vaage M, et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5\u201310 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health. 2019;3(3):166\u201374.","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"7866_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/aogs.14637","volume":"103","author":"G Nilsen","year":"2024","unstructured":"Nilsen G, Simpson MR, Hanem LGE, L\u00f8vvik TS, \u00d8deg\u00e5rd R, Stokkeland LMT, et al. Anthropometrics of neonates born to mothers with PCOS with metformin or placebo exposure in utero. Acta Obstet Gynecol Scand. 2024;103(1):176\u201387.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"7866_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12887-020-1960-2","volume":"20","author":"HK Greger","year":"2020","unstructured":"Greger HK, Hanem LGE, Ostgard HF, Vanky E. Cognitive function in Metformin exposed children, born to mothers with PCOS - follow-up of an RCT. BMC Pediatr. 2020;20(1):60.","journal-title":"BMC Pediatr"},{"issue":"3","key":"7866_CR12","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1210\/jc.2013-3227","volume":"99","author":"S Stridsklev","year":"2014","unstructured":"Stridsklev S, Carlsen SM, Salvesen O, Clemens I, Vanky E. Midpregnancy doppler ultrasound of the uterine artery in metformin- versus placebo-treated PCOS women: a randomized trial. J Clin Endocrinol Metab. 2014;99(3):972\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"7866_CR13","doi-asserted-by":"publisher","first-page":"2604064","DOI":"10.1155\/2018\/2604064","volume":"2018","author":"S Stridsklev","year":"2018","unstructured":"Stridsklev S, Salvesen O, Salvesen KA, Carlsen SM, Vanky E. Uterine artery doppler in pregnancy: women with PCOS compared to healthy controls. Int J Endocrinol. 2018;2018:2604064.","journal-title":"Int J Endocrinol"},{"issue":"6","key":"7866_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1471-0528.2010.02525.x","volume":"117","author":"S Palomba","year":"2010","unstructured":"Palomba S, Falbo A, Russo T, Battista L, Tolino A, Orio F, et al. Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes. BJOG. 2010;117(6):711\u201321.","journal-title":"BJOG"},{"issue":"2","key":"7866_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.fertnstert.2003.06.022","volume":"81","author":"E Vanky","year":"2004","unstructured":"Vanky E, Kj\u00f8tr\u00f8d SB, Maesel A, Bjerve KS, Carlsen SM. Dexamethasone reduces androgen levels in metformin-treated patients with polycystic ovary syndrome. Fertil Steril. 2004;81(2):459\u201362.","journal-title":"Fertil Steril"},{"issue":"5","key":"7866_CR16","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.fertnstert.2004.11.051","volume":"83","author":"E Vanky","year":"2005","unstructured":"Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril. 2005;83(5):1575\u20138.","journal-title":"Fertil Steril"},{"issue":"4","key":"7866_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/uog.3965","volume":"29","author":"KA Salvesen","year":"2007","unstructured":"Salvesen KA, Vanky E, Carlsen SM. Metformin treatment in pregnant women with polycystic ovary syndrome\u2013is reduced complication rate mediated by changes in the uteroplacental circulation? Ultrasound Obstet Gynecol. 2007;29(4):433\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"7866_CR18","doi-asserted-by":"publisher","first-page":"e0262987","DOI":"10.1371\/journal.pone.0262987","volume":"17","author":"S Grindheim","year":"2022","unstructured":"Grindheim S, Ebbing C, Karlsen HO, Skulstad SM, Real FG, L\u00f8nnebotn M, et al. Metformin exposure, maternal PCOS status and fetal venous liver circulation: a randomized, placebo-controlled study. PLoS One. 2022;17(1):e0262987.","journal-title":"PLoS One"},{"issue":"3","key":"7866_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/uog.4088","volume":"30","author":"C Ebbing","year":"2007","unstructured":"Ebbing C, Rasmussen S, Kiserud T. Middle cerebral artery blood flow velocities and pulsatility index and the cerebroplacental pulsatility ratio: longitudinal reference ranges and terms for serial measurements. Ultrasound Obstet Gynecol. 2007;30(3):287\u201396.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"7866_CR20","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ajog.2004.09.019","volume":"192","author":"G Acharya","year":"2005","unstructured":"Acharya G, Wilsgaard T, Berntsen GK, Maltau JM, Kiserud T. Reference ranges for serial measurements of umbilical artery doppler indices in the second half of pregnancy. Am J Obstet Gynecol. 2005;192(3):937\u201344.","journal-title":"Am J Obstet Gynecol"},{"key":"7866_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18.","journal-title":"BMC Med"},{"key":"7866_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115759","author":"MD Owen","year":"2021","unstructured":"Owen MD, Baker BC, Scott EM, Forbes K. Interaction between metformin, folate and vitamin B(12) and the potential impact on fetal growth and long-term metabolic health in diabetic pregnancies. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22115759.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"7866_CR23","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2337\/db23-0089","volume":"72","author":"KS Swenson","year":"2023","unstructured":"Swenson KS, Wang D, Jones AK, Nash MJ, O\u2019Rourke R, Takahashi DL, et al. Metformin disrupts signaling and metabolism in fetal hepatocytes. Diabetes. 2023;72(9):1214\u201327.","journal-title":"Diabetes"},{"issue":"10","key":"7866_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.crad.2020.05.023","volume":"75","author":"AND Dwivedi","year":"2020","unstructured":"Dwivedi AND, Ganesh V, Shukla RC, Jain M, Kumar I. Colour doppler evaluation of uterine and ovarian blood flow in patients of polycystic ovarian disease and post-treatment changes. Clin Radiol. 2020;75(10):772\u20139.","journal-title":"Clin Radiol"},{"issue":"5","key":"7866_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jcu.22006","volume":"41","author":"IA Mohsen","year":"2013","unstructured":"Mohsen IA, Elkattan E, Nabil H, Khattab S. Effect of metformin treatment on endometrial vascular indices in anovulatory obese\/overweight women with polycystic ovarian syndrome using three-dimensional power doppler ultrasonography. J Clin Ultrasound. 2013;41(5):275\u201382.","journal-title":"J Clin Ultrasound"},{"issue":"8","key":"7866_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/00365510802254620","volume":"68","author":"KJ Fougner","year":"2008","unstructured":"Fougner KJ, Vanky E, Carlsen SM. Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study. Scand J Clin Lab Invest. 2008;68(8):771\u20136.","journal-title":"Scand J Clin Lab Invest"},{"issue":"7","key":"7866_CR27","doi-asserted-by":"publisher","first-page":"e0254895","DOI":"10.1371\/journal.pone.0254895","volume":"16","author":"SL Fougner","year":"2021","unstructured":"Fougner SL, Vanky E, L\u00f8vvik TS, Carlsen SM. No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used. PLoS One. 2021;16(7):e0254895.","journal-title":"PLoS One"},{"key":"7866_CR28","doi-asserted-by":"publisher","first-page":"935403","DOI":"10.3389\/fcell.2022.935403","volume":"10","author":"JL Tarry-Adkins","year":"2022","unstructured":"Tarry-Adkins JL, Robinson IG, Reynolds RM, Aye I, Charnock-Jones DS, Jenkins B, et al. Impact of metformin treatment on human placental energy production and oxidative stress. Front Cell Dev Biol. 2022;10:935403.","journal-title":"Front Cell Dev Biol"},{"issue":"2s","key":"7866_CR29","doi-asserted-by":"publisher","first-page":"S928","DOI":"10.1016\/j.ajog.2020.11.005","volume":"226","author":"I Aye","year":"2022","unstructured":"Aye I, Aiken CE, Charnock-Jones DS, Smith GCS. Placental energy metabolism in health and disease-significance of development and implications for preeclampsia. Am J Obstet Gynecol. 2022;226(2s):S928\u201344.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"7866_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374(5):434\u201343.","journal-title":"N Engl J Med"},{"issue":"4","key":"7866_CR31","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1210\/jc.2017-02419","volume":"103","author":"LGE Hanem","year":"2018","unstructured":"Hanem LGE, Stridsklev S, Juliusson PB, Salvesen O, Roelants M, Carlsen SM, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: Follow-Up of two RCTs. J Clin Endocrinol Metabolism. 2018;103(4):1612\u201321.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"6","key":"7866_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.fertnstert.2019.03.015","volume":"111","author":"E Vanky","year":"2019","unstructured":"Vanky E, Engen Hanem LG, Abbott DH. Children born to women with polycystic ovary syndrome-short- and long-term impacts on health and development. Fertil Steril. 2019;111(6):1065\u201375.","journal-title":"Fertil Steril"},{"issue":"1","key":"7866_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.xfre.2024.12.002","volume":"6","author":"LL Berns","year":"2025","unstructured":"Berns LL, Wiegel RE, Koning AHJ, Willemsen SP, Laven JSE, Steegers-Theunissen RPM. Utero-placental (vascular) development throughout pregnancy in women with polycystic ovary syndrome: the Rotterdam periconceptional cohort. F&S Reports. 2025;6(1):79\u201389.","journal-title":"F&S Reports"},{"issue":"1","key":"7866_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2024.2379389","volume":"43","author":"X Guo","year":"2024","unstructured":"Guo X, Yao Y, Wang T, Wu J, Jiang R. The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis. Hypertens Pregnancy. 2024;43(1): 2379389.","journal-title":"Hypertens Pregnancy"},{"issue":"36","key":"7866_CR35","doi-asserted-by":"publisher","first-page":"e2309429","DOI":"10.1002\/advs.202309429","volume":"11","author":"H Lu","year":"2024","unstructured":"Lu H, Jiang H, Li C, Derisoud E, Zhao A, Eriksson G, et al. Dissecting the impact of maternal androgen exposure on developmental programming through targeting the androgen receptor. Adv Sci (Weinh). 2024;11(36):e2309429.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"7866_CR36","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.ajpath.2023.08.008","volume":"193","author":"M Hu","year":"2023","unstructured":"Hu M, Zhang Y, Zhang X, Zhang X, Huang X, Lu Y, et al. Defective uterine spiral artery remodeling and placental senescence in a pregnant rat model of polycystic ovary syndrome. Am J Pathol. 2023;193(12):1916\u201335.","journal-title":"Am J Pathol"},{"key":"7866_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.placenta.2024.07.002","volume":"154","author":"E Sahin","year":"2024","unstructured":"Sahin E, Eraslan Sahin M, Kirlangic MM, Kutuk S, Dagl\u0131tuncezdi Cam S, Can Ozdemir H, et al. Effects of different PCOS phenotypes on placental three-dimensional power doppler indices and placental volume during the first trimester. Placenta. 2024;154:176\u201383.","journal-title":"Placenta"},{"key":"7866_CR38","doi-asserted-by":"publisher","unstructured":"Rial-Crestelo M, Garcia-Otero L, Cancemi A, Giannone M, Escazzocchio E, Biterna A, et al. Prescriptive reference standards of third-trimester cerebroplacental ratio and its physiological determinants. Fetal Diagn Ther. 2020(10). https:\/\/doi.org\/10.1159\/000508366.","DOI":"10.1159\/000508366"},{"issue":"2","key":"7866_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1213\/ANE.0000000000002741","volume":"126","author":"EJ Mascha","year":"2018","unstructured":"Mascha EJ, Vetter TR, Significance. Errors, power, and sample size: the blocking and tackling of statistics. Anesth Analg. 2018;126(2):691\u20138.","journal-title":"Anesth Analg"},{"key":"7866_CR40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214\u201321.","journal-title":"Clin Chim Acta"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07866-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T03:58:38Z","timestamp":1757217518000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07866-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7866"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07866-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Regional Committee for Health Research Ethics of Central Norway approved all the studies included in this project. The Pilot study was approved on 28th of March 2000 (REK-midt 51-2000). The PregMet 2 study was approved on 6th October 2011 and CircMet study approved the 7th of October 2013 (REK-midt 2011\/1434). Approval of further use of data from REK for this study (255504). Alle participants included in this project gave their informed written consent prior to study start. This study has followed the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"749"}}